Heterogeneity in Breast cancer
暂无分享,去创建一个
Yan Zhang | Fang Wang | Hongbo Liu | Yan Zhang | Dongwei Zhang | F. Wang | Y. Wen | Dongwei Zhang | Hongbo Liu | Yanhua Wen
[1] S. Rashid,et al. Hallmarks of Cancer Cell , 2017 .
[2] K. Wani,et al. Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent. , 2014, Molecular medicine reports.
[3] Jicheng Li,et al. BRCA1 Germ‐Line Mutations and Tumor Characteristics in Eastern Chinese Women with Familial Breast Cancer , 2013, Anatomical record.
[4] Y. Bignon,et al. Mutation Screening of the BRCA1 Gene in Early Onset and Familial Breast/Ovarian Cancer in Moroccan Population , 2012, International journal of medical sciences.
[5] T. Spector,et al. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker , 2012, Carcinogenesis.
[6] Tae-Young Roh,et al. Characterization of Chromatin Structure-associated Histone Modifications in Breast Cancer Cells , 2012, Genomics & informatics.
[7] F. Pajonk,et al. Radiation‐Induced Reprogramming of Breast Cancer Cells , 2012, Stem cells.
[8] M. Wicha,et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia , 2012, Proceedings of the National Academy of Sciences.
[9] M. Wei,et al. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients , 2012, Tumor Biology.
[10] R. Gelber,et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] M. J. van de Vijver,et al. An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] A. Pietras. Cancer stem cells in tumor heterogeneity. , 2011, Advances in cancer research.
[13] Karen Gelmon,et al. Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Helena R. Chang,et al. Trastuzumab‐based neoadjuvant therapy in patients with HER2‐positive breast cancer , 2010, Cancer.
[15] A. Di Donna. Antiangiogenic agents. , 2010, Current pharmaceutical design.
[16] K. Polyak,et al. Tumor heterogeneity: causes and consequences. , 2010, Biochimica et biophysica acta.
[17] F. Esteva,et al. Survival among women with triple receptor-negative breast cancer and brain metastases. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Tara L. Naylor,et al. Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer , 2007, Clinical Cancer Research.
[19] Kornelia Polyak,et al. Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution? , 2007, Cell cycle.
[20] J. Andersen,et al. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases , 2007, Breast Cancer Research and Treatment.
[21] J. Mackey,et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[23] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[24] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[25] C. Osborne,et al. Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu , 1992, Breast Cancer Research and Treatment.
[26] M. Nowak,et al. Dynamics of cancer progression , 2004, Nature Reviews Cancer.
[27] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[28] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[29] A. Schäffer,et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. , 1997, Cancer research.
[30] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.